Business Context and Reporting Period
This Form 8-K Current Report was filed by Surgery Partners, Inc. (SGRY) on November 12, 2025. The filing reports a significant executive leadership appointment effective January 1, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
The primary material change is the appointment of Justin Oppenheimer as Chief Operating Officer and National Group President. Mr. Oppenheimer joins the Company from the Hospital for Special Surgery (HSS), where he served for a decade in leadership roles including Chief Strategy Officer and Chief Operating Officer.
Guidance, Outlook, and Management Commentary
The filing does not contain financial guidance, outlook, or management commentary regarding future performance. It details Mr. Oppenheimer's background, including a B.A. from Princeton University and an MBA from Harvard Business School, and notes his service on the Board of Directors for Urban Dove. An Employment Agreement dated October 27, 2025, is referenced as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (Employment Agreement) for specific compensation terms and severance provisions.
- Verify the transition timeline for the new Chief Operating Officer effective January 1, 2026.
- Confirm any potential impact on existing strategic initiatives given the new executive's background at HSS.